港股異動丨越秀交通基建(01052.HK)高開7.69% 年度純利大增812.8%至14.65億元
格隆匯3月9日丨越秀交通基建(01052.HK)高開7.69%,報5.18港元,總市值87億港元。越秀交通基建公佈,截至2021年12月31日止的年度內,集團收入錄得人民幣37.02億元,同比增長26.8%,股東應占盈利為人民幣14.65億元,同比增長812.8%,經營業績再創歷史新高,延續穩定增長的良好態勢。董事會建議派發2021年末期股息每股0.41港元,連同已派發的中期股息每股0.20港元,報吿年度的股息總額為每股0.61港元,相當於人民幣0.4980元,全年派息率相當於56.9%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.